PHAR · Pharming Group N.V. · Documents

$12.13 -0.13 (-1.06%) At close · Oct 29 Q3 2026 earnings call transcript

Market Cap

$859.95M

70.78M

Volume · Oct 29 12.43K Avg daily vol (3M) 25.01K

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2024-10-10	—
6-K	—	2024-09-26	—
6-K	—	2024-08-01	—
6-K	—	2024-05-30	—
6-K	—	2024-05-21	—
6-K	—	2024-05-15	—
6-K	—	2024-05-08	—
6-K	—	2024-04-25	—
6-K	—	2024-04-24	—
6-K	—	2024-04-08	—
20-F	—	2024-04-04	2023-12-31
6-K	—	2024-04-04	—
6-K	—	2024-03-14	—
6-K	—	2024-01-08	—
6-K	—	2023-12-15	2023-12-13
6-K	—	2023-11-13	2023-11-10
6-K	—	2023-10-26	—
6-K	—	2023-09-25	—
6-K	—	2023-08-14	—
6-K	—	2023-08-09	—
6-K	—	2023-08-03	—
6-K	—	2023-07-18	—
6-K	—	2023-06-01	—
6-K	—	2023-05-19	2023-05-17
6-K	—	2023-05-11	—
6-K	—	2023-04-11	—
20-F	—	2023-04-05	2022-12-31
6-K	—	2023-04-05	—
6-K	—	2023-03-27	2023-03-24
6-K	—	2023-03-16	—
6-K	—	2023-03-13	—
6-K	—	2023-03-13	2023-03-12
6-K	—	2023-02-21	—
6-K	—	2023-02-17	2023-02-16
6-K	—	2022-10-27	—
6-K	—	2022-08-04	—
6-K	—	2022-08-02	—
6-K	—	2022-08-01	—
6-K	—	2022-06-02	—
6-K	—	2022-05-18	—
6-K	—	2022-05-12	—
6-K	—	2022-05-05	—
6-K	—	2022-04-26	—
6-K	—	2022-04-22	—
6-K	—	2022-04-06	—
20-F	—	2022-04-06	2021-12-31
6-K	—	2022-04-01	—
6-K	—	2022-03-17	—
6-K	—	2022-03-08	—
6-K	—	2022-02-02	—

Showing 51–100 of 129 filings

Key facts CIK 1828316 CUSIP 71716E105 13F (30d) 2 filings 2 filers Visit website Investor relations